Navigation Links
The Pediatric Dengue Vaccine Initiative Introduces www.DengueWatch.org - a News hub for Tracking Dengue Fever Epidemics Worldwide
Date:3/8/2010

SEOUL, March 9, 2010 /PRNewswire/ -- PDVI (Pediatric Dengue Vaccine Initiative), a program of the International Vaccine Institute (IVI) funded by the Bill & Melinda Gates Foundation, announces today the launch of http://www.denguewatch.org, a news hub for tracking dengue fever epidemics worldwide. Breaking news articles from reliable sources are displayed on a world map according to the location of dengue outbreaks. Dengue fever is endemic in over 100 countries and puts at risk half of the world's population.

"Denguewatch.org is an important public health tool providing instant access to news regarding dengue fever epidemics and their impact on global health," said Dr. John Clemens, IVI Director General, and PDVI Acting Director. "We believe that news reports about dengue hot spots and other important developments can help public health officials track the spread and understand the growing importance of this disease."

Denguewatch.org reports worldwide news alerts provided by Healthmap.org, a freely available Web site. HealthMap is a system based at Children's Hospital Boston, Massachusetts in collaboration with Harvard Medical School, MIT Media Lab and the Harvard-MIT Division of Health Sciences and Technology which integrates outbreak data of varying reliability, ranging from news sources (such as Google News) to curated personal accounts (such as ProMED) to validated official alerts (such as World Health Organization). Dengue news is aggregated and displayed by location for user-friendly access to the original alert.

"The Internet has become a critical medium for clinicians, public health practitioners, and the public seeking health information," said John S. Brownstein, Ph.D., co-founder of Healthmap.org with Clark Freifeld, "We are proud to collaborate with PDVI for http://www.denguewatch.org and we believe it can help foster surveillance and prevention of dengue fever worldwide."

Dengue: a global health threat

Dengue fever is a mosquito-borne disease caused by four types of dengue viruses (type 1 to 4). Overall, the disease is a potential threat for almost half of the world's population. Of the estimated 230 million people infected annually, two million, mostly children, develop dengue hemorrhagic fever (DHF), a severe form of the disease[1]. DHF is a leading cause of hospitalization, placing tremendous pressure on strained medical resources.

Dengue fever occurs mostly in tropical and subtropical countries in Asia and Latin America and is spreading to new parts of the globe each year. In addition, dengue affects countries such as Australia (Queensland) and the United States (Puerto Rico, Texas-Mexico border, Hawaii and the US-affiliated Pacific Islands). A substantial number of people travelling to endemic regions are also infected each year.

Expansion of dengue fever is driven by increased movement of people[2], massive unplanned urbanization, added to a lack of effective mosquito control[3]. Dengue prevention requires fostering a thorough knowledge of the disease.

About PDVI

The Pediatric Dengue Vaccine Initiative, a program of the International Vaccine Institute (IVI) founded in 2001, aims to reduce the burden of dengue disease by accelerating the development, evaluation and introduction of affordable dengue vaccines. PDVI works with public and private partners to accelerate the development and introduction of a dengue vaccine that is safe, effective and affordable for children in endemic countries. PDVI is funded by the Bill & Melinda Gates Foundation. For more information, please visit our website: http://www.pdvi.org

About the IVI

The International Vaccine Institute (IVI) is the world's only international organization devoted exclusively to developing and introducing new and improved vaccines for the world's poorest people, especially children in developing countries. Established as an initiative of the United Nations Development Program in 1997, the IVI operates under a treaty signed by 40 countries and the World Health Organization. IVI conducts research in more than 20 countries in Asia, Africa and Latin America on vaccines against diarrheal infections, bacterial meningitis and pneumonia, Japanese encephalitis, dengue fever and more. For further information, please visit: http://www.ivi.int

---------------------------------

[1] Beatty M Letson GW Margolis HS, Estimating the global burden of dengue., Am J Trop Med Hygiene 81, 5 :231 2009

[2] Mackenzie JS, Gubler DJ, Petersen LR. Nat Med 2004 Dec; 10 (12 Supll) :S98-109

[3] Mackenzie JS, Gubler DJ, Petersen LR. Nat Med 2004 Dec; 10 (12 Supll) :S98-109

SOURCE Pediatric Dengue Vaccine Initiative (PDVI)

Back to top
'/>"/>
SOURCE Pediatric Dengue Vaccine Initiative (PDVI)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Pediatric Home Service (PHS) Named Quality Respiratory Care Provider
2. Sponsors for the 2010 Pediatric Cancer Research Foundation “Reaching for the Cure” Annual Cinco de Mayo Run/Walk Fundraising Event
3. NIH grant will create behavioral health registry for pediatric inflammatory bowel disease
4. Pediatricians Want Redesign of Hot Dogs, Candy to Curb Kids Choking
5. MCG to conduct first FDA-approved stem cell trial in pediatric cerebral palsy
6. Researchers discover new way to kill pediatric brain tumors
7. Possible pharmacological target(s) identified in pediatric OSA
8. New study shows effectiveness of MEND program in prevention and treatment of pediatric obesity
9. Child-specific doses for pediatric PET patients
10. Minimally invasive adult liver donation for pediatric transplantation available exclusively
11. Improved air quality linked to fewer pediatric ear infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Los Angeles, CA (PRWEB) , ... February 08, 2016 , ... ... autism conference held annually in this country. The AutismOne 2016 Conference, which is being ... the truth they often won’t hear elsewhere about helpful interventions and causes of chronic ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... MyDecision™ empowers employers and organizations with the tools and information to lower the ... elements to cut the cost of providing employee healthcare benefits by as much ...
(Date:2/6/2016)... ... February 06, 2016 , ... With the FCPX LUT: Summer ... grades to their footage. A LUT is a Lookup Table that contains a mathematical ... color indicated by the table. By manipulating each pixel, LUT's can change each color ...
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the air at King Kullen! ... assortments and packaging. This staple for Valentine’s Day is a must-have, and can be ... Valentine’s Day, not only are long-stem roses available, but also other flower bouquets, elegantly ...
(Date:2/5/2016)... ... 2016 , ... The event is being held on April 7, 2016 from ... Triumph Over Parkinson’s will fund nearly $100,000 for research for the care and cure ... disease and is the architect of this informative event to raise awareness and funds ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 Summary Breast ... cancer and the most common cancer in women worldwide, ... disease exceedingly prevalent. The number of women diagnosed with ... but the number of deaths has declined due to ... treatment has been revolutionized in the past four decades, ...
(Date:2/4/2016)... VIEW, Calif., Feb. 4, 2016  Omnicell, Inc. (NASDAQ: ... management solutions to healthcare systems, today announced results for ... --> --> GAAP ... $130.3 million, up $5.1 million or 4.1% from the ... 7.2% from the fourth quarter of 2014. Revenue for ...
(Date:2/4/2016)... 4, 2016 In response to the opioid abuse ... Commissioner for Medical Products and Tobacco, along with other FDA ... agency,s approach to opioid medications. The plan will focus on ... in pain access to effective relief. ... , Re-examine the risk-benefit paradigm for opioids and ensure that ...
Breaking Medicine Technology: